Literature DB >> 20080926

The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users.

Ana B Fagundo1, Elisabet Cuyàs, Antonio Verdejo-Garcia, Olha Khymenets, Klaus Langohr, Rocio Martín-Santos, Magí Farré, Rafael de la Torre.   

Abstract

Deficits in verbal fluency associated with ecstasy use have been well established; however, the mechanisms underlying this impairment have yet to be elucidated. In this study we investigated for the first time whether there was a disproportionate impairment in two cognitive subcomponents of verbal fluency: clustering (ability to generate words within the same subcategory) and switching (ability to change the subcategory). We also investigated a possible association between ecstasy use and verbal fluency in subjects genotyped for 5-HTT (5-HTTLPR and 5-HTTVNTR) and COMT (val(108/158)met, rs165599 and rs2097603) polymorphisms, in order to find a potential implication of genetic factors. Ecstasy polydrug users (n = 30) and non-ecstasy users (n = 41) were evaluated in both semantic and phonemic fluency. Results showed that ecstasy users had poorer semantic (but not phonemic) fluency performance than controls. Detailed analysis of clustering and switching performance revealed that this impairment was associated with poorer clustering mechanisms. Clustering was also modulated by the COMT rs165599 polymorphism independently of the group. A specific effect of the 5-HTTLPR polymorphism on switching performance was also found, with ss carriers performing significantly worse than ls and ll carriers, suggesting a serotonin modulation of frontal-executive flexibility. Based on the impaired clustering and switching strategies observed in ecstasy users, it might be proposed that both semantic knowledge and retrieval are impaired in this population. The verbal fluency deficit in ecstasy users may be attributable to a disruption of frontal-striatal circuits directly related with the serotonin function as well as a depletion of lexical-semantic stores mediated by temporal structures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080926     DOI: 10.1177/0269881109354926

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  9 in total

1.  Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.

Authors:  Samanta Yubero-Lahoz; K P C Kuypers; J G Ramaekers; Klaus Langohr; Magí Farré; Rafael de la Torre
Journal:  Psychopharmacology (Berl)       Date:  2014-12-20       Impact factor: 4.530

2.  Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons.

Authors:  Amy K Goodwin; Melanie Mueller; Courtney D Shell; George A Ricaurte; Nancy A Ator
Journal:  J Pharmacol Exp Ther       Date:  2013-03-20       Impact factor: 4.030

3.  The influence of genetic and environmental factors among MDMA users in cognitive performance.

Authors:  Elisabet Cuyàs; Antonio Verdejo-García; Ana Beatriz Fagundo; Olha Khymenets; Joan Rodríguez; Aida Cuenca; Susana de Sola Llopis; Klaus Langohr; Jordi Peña-Casanova; Marta Torrens; Rocío Martín-Santos; Magí Farré; Rafael de la Torre
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

4.  Meta-analysis of executive functioning in ecstasy/polydrug users.

Authors:  C A Roberts; A Jones; C Montgomery
Journal:  Psychol Med       Date:  2016-03-11       Impact factor: 7.723

5.  COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population.

Authors:  Hasan Mervan Aytac; Yasemin Oyaci; Pinar Cetinay Aydin; Mustafa Pehlivan; Sacide Pehlivan
Journal:  Neurosciences (Riyadh)       Date:  2022-01       Impact factor: 0.735

6.  Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT).

Authors:  Ricardo Pardo-Lozano; Magí Farré; Samanta Yubero-Lahoz; Brian O'Mathúna; Marta Torrens; Cristina Mustata; Clara Pérez-Mañá; Klaus Langohr; Elisabet Cuyàs; Marcel lí Carbó; Rafael de la Torre
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

7.  5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study.

Authors:  Natasha E Wright; Judith A Strong; Erika R Gilbart; Skyler G Shollenbarger; Krista M Lisdahl
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

8.  Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Aβ42 Concentrations in Down Syndrome Young Adults.

Authors:  Laura Del Hoyo; Laura Xicota; Gonzalo Sánchez-Benavides; Aida Cuenca-Royo; Susana de Sola; Klaus Langohr; Ana B Fagundo; Magí Farré; Mara Dierssen; Rafael de la Torre
Journal:  Front Behav Neurosci       Date:  2015-11-18       Impact factor: 3.558

9.  Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter.

Authors:  K P C Kuypers; R de la Torre; M Farre; L Xicota; E B de Sousa Fernandes Perna; E L Theunissen; J G Ramaekers
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.